http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23453808

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Research Support, Non-U.S. Gov't
endingPage 2083
issn 0923-7534
issueIdentifier 12
pageRange 2079-2083
publicationName Annals of oncology : official journal of the European Society for Medical Oncology
startingPage 2079
bibliographicCitation Lee J, Suh C, Kang HJ, Ryoo B-, Huh J, Ko YH, Eom H-, Kim K, Park K, Kim WS. Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma. Annals of Oncology. 2008 Dec;19(12):2079–83. doi: 10.1093/annonc/mdn431.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e602653a798b3205a5cff09aa9c6f053
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ad087920d63afc9006cf180e49f378d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b5d65652cb0f480ae4a1267f7546962
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81a7a25c65f9a69ccc367a1605890a8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7148615aca86e180511f849f3f7bd906
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3777f6d47cde19f1e0c3328df9c20557
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59eb6e357a02f1537e3ac6e82b3284f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a99e6e21275a08d87588df3e2b9da8f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07e380f2697c73758dbbca478f102216
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e437d896f15fdfda1138f658d07adf06
date 200812
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2733119
https://doi.org/10.1093/annonc/mdn431
https://pubmed.ncbi.nlm.nih.gov/18689866
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1846
https://portal.issn.org/resource/ISSN/0923-7534
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
discusses http://id.nlm.nih.gov/mesh/M0022676
http://id.nlm.nih.gov/mesh/M0002834
http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0350110
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0018225
http://id.nlm.nih.gov/mesh/M0140424
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001897Q000008
http://id.nlm.nih.gov/mesh/D011719Q000008
http://id.nlm.nih.gov/mesh/D000971Q000008
http://id.nlm.nih.gov/mesh/D016399Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D046988Q000187
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D001897Q000009
http://id.nlm.nih.gov/mesh/D011719Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003520
http://id.nlm.nih.gov/mesh/D014750
http://id.nlm.nih.gov/mesh/D000971Q000009
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D004317
http://id.nlm.nih.gov/mesh/D011241
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D000069286
http://id.nlm.nih.gov/mesh/D020714
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11056
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243055978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924

Total number of triples: 80.